AstraZeneca, Boehringer Ingelheim, GSK defend patent listings as Klobuchar amps up pressure

January 20, 2024• by

Sen. Amy Klobuchar (D–MN) is pressuring six pharma companies to remove improperly listed patents from the FDA’s Orange Book by the end of the …

Full story here.

More Sen. Klobuchar News

Published by endpts.com

Visited 1 times, 1 visit(s) today

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Close Search Window
↑
Designed by Dannci